Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3989288 | Journal of Thoracic Oncology | 2016 | 7 Pages |
Abstract
This study assessed the reliable and assessable data on the chemotherapy regimens for TC to identify the evidence-based recommendations. The results indicate that the only recommended anthracycline-containing regimen would be carboplatin plus amrubicin-not the combination of cisplatin, doxorubicin, vincristine, and cyclophosphamide-and that the recommended regimens without anthracycline would be carboplatin plus paclitaxel and cisplatin plus docetaxel.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Fumihiko MD, PhD, Ryo MD, Kaname MD, Takashi MD, PhD,